QSAM Biosciences, Inc. Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details) - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Details
Net Income (Loss)	$ 586,470	$ 4,746,495
Accumulated deficit	6,250,988	$ 5,664,518
Working Capital Deficit	$ 717,221

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.